This application relates to a compound of formula I (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.

The present invention is an aromatic evaporator consisting of a base, a heater, a heat conduction aluminum plate, a constant temperature controller, a plug, a ceramic carriers and a cover. The plug sets inside the base to deliver D.C. power; the heater converts the electricity from the plug into heat; the heat conduction aluminum plate adhered to the heater directly evens the heat; the constant temperature controller contains the electric conduction switch and the memory alloy plate connected wi...

Disclosed is an aromatic compound expressed by the general formula (I), wherein A represents of a fused aromatic hydrocarbon moiety such as triphenylene, X represents a hydrogen-bonding site such as an atomic group containing an amide linkage, Y represents a chain functional group such as an alkyl group having 3 to 18, preferably 10 to 18 carbon atoms, and n represents an integer ranging from 2 to 10. The aromatic compound forms a molecular assembly in which the aromatic rings mutually overlap a...

This application relates to a compound of formula I (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.

The present invention relates to compounds of formula I wherein the substituents are as defined below. The compounds of formula I are useful for the treatment of diseases such as schizophrenia, including both the positive and the negative symptoms of schizophrenia and other psychoses. ##STR00001##

This application relates to a compound of formula I (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.

The invention relates to polyetherketones and to a process for the preparation of aromatic polyetherketones which process comprises: a) self-condensing a compound of formula (I) wherein n represents 0 or 1 in the presence of an alkyl or optionally substituted aryl sulphonic acid solvent and in the absence of phosphorous pentoxide; or b) condensing a compound of general formula (II) and a compound of general formula (III) wherein p and q independently represent 0 or 1, in the presence of an alkyl...

Aromatic and heteroaromatic amides of the formula ##STR1## where R.sup.1, R.sup.2 and R.sup.3 can be alkyl, X is alkylene, and R.sup.4 is an unsubstituted or substituted aromatic or heteroaromatic group such as naphthyl or fluorenyl, are CNS agents useful for treating pain, depression, anxiety, seizures, and schizophrenia.

The present invention provides an aromatic polyester which is obtained by condensation polymerization reaction of terephthalic acid, 2,6-naphthalenedicarboxylic acid and acylated product obtained by acylation of parahydroxybenzoic acid and hydroquinone with fatty acid anhydride, wherein said aromatic polyester satisfy the following conditions (A) to (D), and the acylation and/or the condensation polymerization reaction are conducted in the presence of heterocyclic organic compound containing at ...

Loss of aromatics in the raffinate removed from an extractive distillation zone is diminished by reboiling a dilute water-solvent mixture with the extractive distillation lean solvent feed.